The FDA has approved many Buprenorphine based medications to treat opioid dependence, including Suboxone. Here are a few of the most common ones:
Bunavail (buprenorphine and naloxone) buccal film: Bunavail uses BDSI’s proprietary BioErodible MucoAdhesive (BEMA) delivery technology, also called a buccal film, which adheres to the inside of the cheek. Bunavail has double the bioavailability of Suboxone Film (and generics) and as a result only half the buprenorphine is required per dose. The lower dose may reduce side effects, such as constipation.
Zubsolv (buprenorphine and naloxone) sublingual tablets: Zubsolv comes in tablet form that is supposed to be consumed by placing it under the toungue. It has a higher bioavailability than Suboxone and as a result comes in different doses than Suboxone or generics. Hence, it comes in sizes of 5.7-mg/1.4-mg (buprenorphine/naloxone), and 1.4-mg/0.36-mg (buprenorphine/naloxone) both have equal bioavailability to 8mg/2mg and 4mg/1mg of competing buprenorphine/naloxone products, respectively.
Generic Buprenorphine/Naloxone sublingual tablets: A generic version of Suboxone that is typically the cheapest Buprenorphine/Naloxone medication on the market. It comes in a tablet form that is supposed to be consumed by placing it under the toungue.
how Suboxone treatment can work